Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Terns Pharma
(NASDAQ:TERN)
Intraday
$4.30
-0.29
[-6.32%]
After-Hours
$4.30
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$4.30
-0.29
[-6.32%]
At close: Apr 19
$4.30
0
[0.00%]
PreMarket: 6:03AM EDT
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Terns Pharma Stock (NASDAQ:TERN)
Terns Pharma Stock (NASDAQ: TERN)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, March 27, 2024
UBS Maintains Buy on Terns Pharma, Lowers Price Target to $18
Benzinga Newsdesk
-
Mar 27, 2024, 2:17PM
Thursday, March 21, 2024
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
-
Mar 21, 2024, 5:33PM
Monday, March 18, 2024
Terns Pharmaceuticals shares are trading lower after JMP Securities maintained an Outperform rating on the stock but lowered its price target from $17 to $15.
Benzinga Newsdesk
-
Mar 18, 2024, 1:05PM
JMP Securities Maintains Outperform on Terns Pharma, Lowers Price Target to $15
Benzinga Newsdesk
-
Mar 18, 2024, 7:01AM
Friday, March 15, 2024
BMO Capital Maintains Outperform on Terns Pharma, Raises Price Target to $19
Benzinga Newsdesk
-
Mar 15, 2024, 11:01AM
HC Wainwright & Co. Reiterates Neutral on Terns Pharma, Maintains $5.5 Price Target
Benzinga Newsdesk
-
Mar 15, 2024, 6:25AM
Thursday, March 14, 2024
Terns Pharma Q4 EPS $(0.29), Inline
Happy Mohamed
-
Mar 14, 2024, 4:15PM
Monday, March 11, 2024
Terns Pharmaceuticals Secures FDA Orphan Drug Designation For TERN-701 For Treatment Of Chronic Myeloid Leukemia
Benzinga Newsdesk
-
Mar 11, 2024, 4:06PM
Friday, February 09, 2024
Why Take-Two Interactive Software Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Avi Kapoor
-
Feb 9, 2024, 1:18PM
Wednesday, February 07, 2024
Terns Pharmaceuticals Appoints Amy Burroughs As CEO
Benzinga Newsdesk
-
Feb 7, 2024, 8:17AM
Wednesday, January 10, 2024
HC Wainwright & Co. Maintains Neutral on Terns Pharma, Lowers Price Target to $5.5
Benzinga Newsdesk
-
Jan 10, 2024, 6:25AM
Tuesday, December 05, 2023
JMP Securities Reiterates Market Outperform on Terns Pharma, Maintains $17 Price Target
Benzinga Newsdesk
-
Dec 5, 2023, 9:30AM
Top 5 Health Care Stocks That Are Ticking Portfolio Bombs
Lisa Levin
-
Dec 5, 2023, 9:05AM
Monday, December 04, 2023
Why U Power Shares Are Trading Lower By Around 54%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Lisa Levin
-
Dec 4, 2023, 1:10PM
SAIC Reports Q3 Results, Joins Uber, Wallbox And Other Big Stocks Moving Higher On Monday
Lisa Levin
-
Dec 4, 2023, 10:33AM
Monday, November 27, 2023
Mizuho Maintains Buy on Terns Pharma, Lowers Price Target to $10
Benzinga Newsdesk
-
Nov 27, 2023, 11:36AM
Tuesday, November 14, 2023
Recap: Terns Pharma Q3 Earnings
Benzinga Insights
-
Nov 14, 2023, 9:10AM
Terns Pharma Q3 EPS $(0.42) Vs $(0.44) YoY, Cash Balance of $267M Likely to Provide Runway into 2026
Benzinga Newsdesk
-
Nov 14, 2023, 8:10AM
Monday, November 13, 2023
Terns Pharmaceuticals Presents Data From Phase 2a DUET Trial Of THR-β Agonist TERN-501 In NASH At AASLD The Liver Meeting 2023
Benzinga Newsdesk
-
Nov 13, 2023, 8:31AM
Thursday, November 02, 2023
Terns Pharmaceuticals Announces First Participant Dosed In Phase 1 Clinical Trial Of TERN-601 Oral GLP-1 Receptor Agonist For Treatment Of Obesity
Benzinga Newsdesk
-
Nov 2, 2023, 5:19PM
Monday, October 16, 2023
Terns Pharmaceuticals Announces Global Phase 1 Clinical Trial Design Of TERN-701 For The Treatment Of Chronic Myeloid Leukemia
Benzinga Newsdesk
-
Oct 16, 2023, 8:15AM
Thursday, August 10, 2023
Global Payments To Rally Around 17%? Here Are 10 Other Analyst Forecasts For Thursday
Lisa Levin
-
Aug 10, 2023, 7:53AM
HC Wainwright & Co. Maintains Neutral on Terns Pharma, Lowers Price Target to $8
Benzinga Newsdesk
-
Aug 10, 2023, 4:48AM
Wednesday, August 09, 2023
Terns Pharmaceuticals shares are trading lower. The company late Tuesday reported top-line results from the Phase 2a DUET clinical trial of TERN-501.
Benzinga Newsdesk
-
Aug 9, 2023, 3:31PM
JP Morgan Maintains Neutral on Terns Pharma, Raises Price Target to $11
Benzinga Newsdesk
-
Aug 9, 2023, 12:40PM
Tuesday, August 08, 2023
Terns Pharma Q2 EPS $(0.25) Beats $(0.34) Estimate
Benzinga Newsdesk
-
Aug 8, 2023, 5:43PM
Terns Achieves Primary Endpoint And All Secondary Endpoints In Phase 2a DUET Trial Of THR-β Agonist TERN-501 In NASH
Happy Mohamed
-
Aug 8, 2023, 5:42PM
Roth MKM Reiterates Buy on Terns Pharma, Maintains $23 Price Target
Benzinga Newsdesk
-
Aug 8, 2023, 10:43AM
Thursday, August 03, 2023
Terns Pharmaceuticals Announces CEO Senthil Sundaram Has Resigned; Erin Quirk To Assume Leadership
Benzinga Newsdesk
-
Aug 3, 2023, 5:31PM
Wednesday, July 26, 2023
12 Analysts Have This to Say About Terns Pharma
Benzinga Insights
-
Jul 26, 2023, 11:00AM
JMP Securities Reiterates Market Outperform on Terns Pharma, Maintains $17 Price Target
Benzinga Newsdesk
-
Jul 26, 2023, 8:33AM
Friday, June 30, 2023
Roth MKM Reiterates Buy on Terns Pharma, Maintains $23 Price Target
Benzinga Newsdesk
-
Jun 30, 2023, 10:22AM
JMP Securities Reiterates Market Outperform on Terns Pharma, Maintains $17 Price Target
Benzinga Newsdesk
-
Jun 30, 2023, 9:23AM
Mizuho Reiterates Buy on Terns Pharma, Maintains $16 Price Target
Benzinga Newsdesk
-
Jun 30, 2023, 8:43AM
Wednesday, June 28, 2023
Terns Pharmaceuticals Is "Attractively Priced" Despite Pressure From Eli Lilly's Obesity Data, Analyst Says
Vandana Singh
-
Jun 28, 2023, 2:53PM
Tuesday, June 27, 2023
Why Walgreens Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin
-
Jun 27, 2023, 1:56PM
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
-
Jun 27, 2023, 1:37PM
Terns Pharmaceuticals shares are trading lower. The company announced new preclinical data for the TERN-601 program in obesity at the ADA's 83rd Annual Scientific Sessions.
Benzinga Newsdesk
-
Jun 27, 2023, 12:24PM
Mizuho Reiterates Buy on Terns Pharma, Maintains $16 Price Target
Benzinga Newsdesk
-
Jun 27, 2023, 8:03AM
Monday, June 26, 2023
Terns Pharmaceuticals Highlights New Preclinical Data For TERN-601 Program In Obesity At The ADA's 83rd Annual Scientific Session And Upcoming Events
Happy Mohamed
-
Jun 26, 2023, 4:07PM
Thursday, June 22, 2023
Expert Ratings for Terns Pharma
Benzinga Insights
-
Jun 22, 2023, 4:01PM
Terns Pharma Has 35% Upside According To This Analyst, NASH Asset To Drive Valuation
Vandana Singh
-
Jun 22, 2023, 2:54PM
Benzinga's Top Ratings Upgrades, Downgrades For June 22, 2023
Benzinga Insights
-
Jun 22, 2023, 11:02AM
Mizuho Initiates Coverage On Terns Pharma with Buy Rating, Announces Price Target of $16
Benzinga Newsdesk
-
Jun 22, 2023, 5:42AM
Wednesday, June 07, 2023
Benzinga's Top Ratings Upgrades, Downgrades For June 7, 2023
Benzinga Insights
-
Jun 7, 2023, 11:00AM
Jefferies Initiates Coverage On Terns Pharma with Buy Rating, Announces Price Target of $18
Benzinga Newsdesk
-
Jun 7, 2023, 5:24AM
Wednesday, May 31, 2023
Benzinga's Top Ratings Upgrades, Downgrades For May 31, 2023
Benzinga Insights
-
May 31, 2023, 11:00AM
8 Analysts Have This to Say About Terns Pharma
Benzinga Insights
-
May 31, 2023, 10:01AM
Roth MKM Initiates Coverage On Terns Pharma with Buy Rating, Announces Price Target of $23
Benzinga Newsdesk
-
May 31, 2023, 4:30AM
Thursday, May 25, 2023
Terns Pharmaceuticals Announces Publication Of TERN-701 Trial-In-Progress Abstract For 2023 ASCO Meeting
Benzinga Newsdesk
-
May 25, 2023, 5:12PM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch